US Stock MarketDetailed Quotes

PPBT Purple Biotech

Watchlist
  • 3.700
  • +0.280+8.19%
Close Dec 23 16:00 ET
  • 3.760
  • +0.060+1.62%
Post 16:55 ET
9.56MMarket Cap-0.50P/E (TTM)

Purple Biotech Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-62.88%2.13M
-36.59%3.26M
-12.81%4.47M
-1.47%22.27M
-5.06%6.27M
13.11%5.75M
43.04%5.14M
-30.13%5.12M
26.03%22.6M
39.29%6.6M
Selling and administrative expenses
-32.21%785K
-39.51%865K
-35.78%1.04M
-18.79%4.84M
-56.85%630K
-28.34%1.16M
-5.11%1.43M
17.77%1.62M
2.42%5.96M
20.86%1.46M
-General and administrative expense
----
----
----
-18.79%4.84M
----
----
----
----
2.42%5.96M
----
Research and development costs
-70.63%1.35M
-35.47%2.39M
-2.14%3.42M
4.38%17.03M
8.76%5.24M
32.44%4.59M
77.87%3.71M
-41.23%3.5M
37.99%16.32M
48.54%4.82M
Depreciation amortization depletion
----
----
----
-1.00%199K
----
----
----
----
-12.99%201K
----
-Depreciation and amortization
----
----
----
-1.00%199K
----
----
----
----
-12.99%201K
----
Other operating expenses
----
----
----
63.33%196K
----
----
----
----
118.18%120K
----
Operating profit
62.88%-2.13M
36.59%-3.26M
12.81%-4.47M
1.47%-22.27M
5.06%-6.27M
-13.11%-5.75M
-43.04%-5.14M
30.13%-5.12M
-26.03%-22.6M
-39.29%-6.6M
Net non-operating interest income expense
-155.06%-381K
488.00%97K
212.79%685K
-418.47%-1.71M
-1,133.07%-2.59M
198.28%692K
-165.79%-25K
1,360.00%219K
122.41%536K
109.17%251K
Non-operating interest income
-81.64%130K
-1.63%121K
152.52%702K
-10.90%474K
-556.83%-635K
185.48%708K
38.20%123K
396.43%278K
66.25%532K
148.21%139K
Non-operating interest expense
3,093.75%511K
-83.78%24K
-71.19%17K
-16.42%56K
-307.32%-167K
0.00%16K
190.20%148K
43.90%59K
-15.19%67K
35.94%-41K
Total other finance cost
----
----
----
3,092.96%2.13M
----
----
----
----
---71K
----
Other net income (expense)
1.85M
744K
1,203.26%4M
330.83%307K
Gain on sale of security
--1.85M
--946K
----
1,203.26%4M
----
----
----
----
330.83%307K
----
Special income (charges)
--0
---202K
----
----
----
--0
--0
----
----
----
-Write off
--0
--202K
----
----
----
--0
--0
----
----
----
Income before tax
86.79%-668K
53.20%-2.42M
22.88%-3.78M
8.19%-19.98M
19.59%-4.86M
-4.25%-5.06M
-45.27%-5.16M
32.98%-4.9M
-22.07%-21.76M
-27.17%-6.04M
Income tax
Net income
86.79%-668K
53.20%-2.42M
22.88%-3.78M
8.19%-19.98M
19.59%-4.86M
-4.25%-5.06M
-45.27%-5.16M
32.98%-4.9M
-17.83%-21.76M
-18.35%-6.04M
Net income continuous Operations
86.79%-668K
53.20%-2.42M
22.88%-3.78M
8.19%-19.98M
19.59%-4.86M
-4.25%-5.06M
-45.27%-5.16M
32.98%-4.9M
-22.07%-21.76M
-27.17%-6.04M
Net income discontinuous operations
----
----
----
--0
----
----
----
----
--0
----
Minority interest income
73.68%-5K
54.55%-10K
24.00%-19K
-5.43%-97K
3.13%-31K
24.00%-19K
-37.50%-22K
-31.58%-25K
-9.52%-92K
5.88%-32K
Net income attributable to the parent company
86.83%-663K
53.19%-2.41M
22.88%-3.76M
8.25%-19.88M
19.68%-4.83M
-4.39%-5.04M
-45.31%-5.14M
33.15%-4.88M
-17.86%-21.67M
-18.51%-6.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
86.83%-663K
53.19%-2.41M
22.88%-3.76M
8.25%-19.88M
19.68%-4.83M
-4.39%-5.04M
-45.31%-5.14M
33.15%-4.88M
-17.86%-21.67M
-18.51%-6.01M
Basic earnings per share
91.58%-0.39
64.00%-1.8
44.00%-2.8
25.00%-18
46.52%-3.53
14.26%-4.63
-25.00%-5
39.02%-5
14.89%-24
49.23%-6.6
Diluted earnings per share
91.58%-0.39
64.00%-1.8
44.00%-2.8
25.00%-18
46.52%-3.53
14.26%-4.63
-25.00%-5
39.02%-5
14.89%-24
49.23%-6.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -62.88%2.13M-36.59%3.26M-12.81%4.47M-1.47%22.27M-5.06%6.27M13.11%5.75M43.04%5.14M-30.13%5.12M26.03%22.6M39.29%6.6M
Selling and administrative expenses -32.21%785K-39.51%865K-35.78%1.04M-18.79%4.84M-56.85%630K-28.34%1.16M-5.11%1.43M17.77%1.62M2.42%5.96M20.86%1.46M
-General and administrative expense -------------18.79%4.84M----------------2.42%5.96M----
Research and development costs -70.63%1.35M-35.47%2.39M-2.14%3.42M4.38%17.03M8.76%5.24M32.44%4.59M77.87%3.71M-41.23%3.5M37.99%16.32M48.54%4.82M
Depreciation amortization depletion -------------1.00%199K-----------------12.99%201K----
-Depreciation and amortization -------------1.00%199K-----------------12.99%201K----
Other operating expenses ------------63.33%196K----------------118.18%120K----
Operating profit 62.88%-2.13M36.59%-3.26M12.81%-4.47M1.47%-22.27M5.06%-6.27M-13.11%-5.75M-43.04%-5.14M30.13%-5.12M-26.03%-22.6M-39.29%-6.6M
Net non-operating interest income expense -155.06%-381K488.00%97K212.79%685K-418.47%-1.71M-1,133.07%-2.59M198.28%692K-165.79%-25K1,360.00%219K122.41%536K109.17%251K
Non-operating interest income -81.64%130K-1.63%121K152.52%702K-10.90%474K-556.83%-635K185.48%708K38.20%123K396.43%278K66.25%532K148.21%139K
Non-operating interest expense 3,093.75%511K-83.78%24K-71.19%17K-16.42%56K-307.32%-167K0.00%16K190.20%148K43.90%59K-15.19%67K35.94%-41K
Total other finance cost ------------3,092.96%2.13M-------------------71K----
Other net income (expense) 1.85M744K1,203.26%4M330.83%307K
Gain on sale of security --1.85M--946K----1,203.26%4M----------------330.83%307K----
Special income (charges) --0---202K--------------0--0------------
-Write off --0--202K--------------0--0------------
Income before tax 86.79%-668K53.20%-2.42M22.88%-3.78M8.19%-19.98M19.59%-4.86M-4.25%-5.06M-45.27%-5.16M32.98%-4.9M-22.07%-21.76M-27.17%-6.04M
Income tax
Net income 86.79%-668K53.20%-2.42M22.88%-3.78M8.19%-19.98M19.59%-4.86M-4.25%-5.06M-45.27%-5.16M32.98%-4.9M-17.83%-21.76M-18.35%-6.04M
Net income continuous Operations 86.79%-668K53.20%-2.42M22.88%-3.78M8.19%-19.98M19.59%-4.86M-4.25%-5.06M-45.27%-5.16M32.98%-4.9M-22.07%-21.76M-27.17%-6.04M
Net income discontinuous operations --------------0------------------0----
Minority interest income 73.68%-5K54.55%-10K24.00%-19K-5.43%-97K3.13%-31K24.00%-19K-37.50%-22K-31.58%-25K-9.52%-92K5.88%-32K
Net income attributable to the parent company 86.83%-663K53.19%-2.41M22.88%-3.76M8.25%-19.88M19.68%-4.83M-4.39%-5.04M-45.31%-5.14M33.15%-4.88M-17.86%-21.67M-18.51%-6.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 86.83%-663K53.19%-2.41M22.88%-3.76M8.25%-19.88M19.68%-4.83M-4.39%-5.04M-45.31%-5.14M33.15%-4.88M-17.86%-21.67M-18.51%-6.01M
Basic earnings per share 91.58%-0.3964.00%-1.844.00%-2.825.00%-1846.52%-3.5314.26%-4.63-25.00%-539.02%-514.89%-2449.23%-6.6
Diluted earnings per share 91.58%-0.3964.00%-1.844.00%-2.825.00%-1846.52%-3.5314.26%-4.63-25.00%-539.02%-514.89%-2449.23%-6.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data